These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31520405)

  • 1. Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World Setting.
    Kim RB
    Clin Pharmacol Ther; 2019 Nov; 106(5):933-935. PubMed ID: 31520405
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing Increased Accessibility to Pharmacogenomic Data.
    Haga SB
    Clin Pharmacol Ther; 2019 Nov; 106(5):922-924. PubMed ID: 31482575
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.
    Chenoweth MJ; Giacomini KM; Pirmohamed M; Hill SL; van Schaik RHN; Schwab M; Shuldiner AR; Relling MV; Tyndale RF
    Clin Pharmacol Ther; 2020 Jan; 107(1):57-61. PubMed ID: 31696505
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
    Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
    Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics in daily practice].
    van Gelder T; van Schaik RHN
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
    Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
    Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Black box" pharmacogenetic decision-support tools in psychiatry.
    Bousman CA; Eyre HA
    Braz J Psychiatry; 2020 Apr; 42(2):113-115. PubMed ID: 31994639
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
    Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
    Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
    [No Abstract]   [Full Text] [Related]  

  • 11. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementing a personalized medicine program in a community health system.
    Dressler LG; Bell GC; Ruch KD; Retamal JD; Krug PB; Paulus RA
    Pharmacogenomics; 2018 Nov; 19(17):1345-1356. PubMed ID: 30345883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.
    Rosenman MB; Decker B; Levy KD; Holmes AM; Pratt VM; Eadon MT
    Value Health; 2017 Jan; 20(1):54-59. PubMed ID: 28212969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
    Hayward J; McDermott J; Qureshi N; Newman W
    Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.
    Kisor DF; Monte AA; Müller DJ
    Pharmacogenomics; 2020 May; 21(7):427-430. PubMed ID: 32319356
    [No Abstract]   [Full Text] [Related]  

  • 17. Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.
    Bousman CA; Zierhut H; Müller DJ
    Clin Pharmacol Ther; 2019 Aug; 106(2):309-312. PubMed ID: 31004441
    [No Abstract]   [Full Text] [Related]  

  • 18. Educating patients and providers through comprehensive pharmacogenetic test reports.
    Haga SB
    Pharmacogenomics; 2017 Jul; 18(11):1047-1050. PubMed ID: 28686141
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.